Divergent tissue and sex effects of rapamycin on the proteasome-chaperone network of old mice

Frontiers in Molecular Neuroscience

Volumn 7, Issue November, 2014, Pages 1-17

  Rodriguez, Karl A ^a,b   Dodds, Sherry G ^a   Strong, Randy ^a,b   Galvan, Veronica ^a,b   Sharp, Z D ^a   Buffenstein, Rochelle ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Heat shock proteins; Longevity; mTOR; Proteasome; Rapamycin; Sexual dimorphic effects

Indexed keywords

CHAPERONE; CHYMOTRYPSIN; HEAT SHOCK TRANSCRIPTION FACTOR 1; PROTEASOME; PROTEASOME INHIBITOR; RAPAMYCIN; TRYPTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GEL ELECTROPHORESIS; MALE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; SEX DIFFERENCE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84908622526     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2014.00083     Document Type: Article

References (61)

1. Babbitt, S. E., Kiss, A., Deffenbaugh, A. E., Chang, Y. H., Bailly, E., Erdjument-Bromage, H., et al. (2005). ATP hydrolysis-dependent disassembly of the 26S proteasome is part of the catalytic cycle. Cell 121, 553-565. doi: 10.1016/j.cell.2005.03.028
2. Balasubramanian, S., Kanade, S., Han, B., and Eckert, R. L. (2012). A proteasome inhibitor-stimulated Nrf1 protein-dependent compensatory increase in proteasome subunit gene expression reduces polycomb group protein level.J. Biol. Chem. 287, 36179-36189. doi: 10.1074/jbc.M112.359281
3. Bonelli, M. A., Desenzani, S., Cavallini, G., Donati, A., Romani, A. A., Bergamini, E., et al. (2008). Low-level caloric restriction rescues proteasome activity and Hsc70 level in liver of aged rats. Biogerontology 9, 1-10. doi: 10.1007/s10522-007-9111-9
4. Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., et al. (2002). Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507-511. doi: 10.1038/416507a
5. Chang, T. L., Chang, C. J., Lee, W. Y., Lin, M. N., Huang, Y. W., and Fan, K. (2009). The roles of ubiquitin and 26S proteasome in human obesity. Metabolism 58, 1643-1648. doi: 10.1016/j.metabol.2009.05.020
6. Chondrogianni, N., Petropoulos, I., Franceschi, C., Friguet, B., and Gonos, E. S. (2000). Fibroblast cultures from healthy centenarians have an active proteasome. Exp. Gerontol. 35, 721-728. doi: 10.1016/S0531-5565(00)00137-6
7. Chou, S. D., Prince, T., Gong, J., and Calderwood, S. K. (2012). mTOR is essential for the proteotoxic stress response, HSF1 activation and heat shock protein synthesis. PLoS ONE 7:e39679. doi: 10.1371/journal.pone.0039679
8. Cuesta, R., Laroia, G., and Schneider, R. J. (2000). Chaperone hsp27 inhibits translation during heat shock by binding eIF4G and facilitating dissociation of cap-initiation complexes. Genes Dev. 14, 1460-1470. doi: 10.1101/gad.14.12.1460
9. Dasuri, K., Zhang, L., Ebenezer, P., Fernandez-Kim, S. O., Bruce-Keller, A. J., Szweda, L. I., et al. (2011). Proteasome alterations during adipose differentiation and aging: links to impaired adipocyte differentiation and development of oxidative stress. Free Radic. Biol. Med. 51, 1727-1735. doi: 10.1016/j.freeradbiomed.2011.08.001
10. David, D. C., Ollikainen, N., Trinidad, J. C., Cary, M. P., Burlingame, A. L., and Kenyon, C. (2010). Widespread protein aggregation as an inherent part of aging in C. elegans. PLoS Biol. 8:e1000450. doi: 10.1371/journal.pbio.1000450
11. De Hoon, M. (2002). Cluster 3.0 Manual. Available Online at:http://bonsai.hgc.jp/~mdehoon/software/cluster/manual/Contents.html#Contents: Univeristy of Tokyo (Accessed November 5, 2002).
12. Demartino, G. N., and Gillette, T. G. (2007). Proteasomes: machines for all reasons. Cell 129, 659-662. doi: 10.1016/j.cell.2007.05.007
13. Dickey, C. A., Patterson, C., Dickson, D., and Petrucelli, L. (2007). Brain CHIP: removing the culprits in neurodegenerative disease. Trends Mol. Med. 13, 32-38. doi: 10.1016/j.molmed.2006.11.003
14. Edrey, Y. H., Oddo, S., Cornelius, C., Caccamo, A., Calabrese, V., and Buffenstein, R. (2014). Oxidative damage and amyloid-beta metabolism in brain regions of the longest-lived rodents. J. Neurosci. Res. 92, 195-205. doi: 10.1002/jnr.23320
15. Elasser, S., Schmidt, M., and Finley, D. (2005). Characterization of the proteasome using native gel electrophoresis.Meth. Enzymol. 398, 353-363. doi: 10.1016/S0076-6879(05)98029-4
16. Ferrington, D. A., Husom, A. D., and Thompson, L. V. (2005). Altered proteasome structure, function, and oxidation in aged muscle. FASEB J. 19, 644-646. doi: 10.1096/fj.04-2578fje
17. Fok, W. C., Chen, Y., Bokov, A., Zhang, Y., Salmon, A. B., Diaz, V., et al. (2014). Mice fed rapamycin have an increase in lifespan associated with major changes in the liver transcriptome. PLoS ONE 9:e83988. doi: 10.1371/journal.pone.0083988
18. Goldbaum, O., Riedel, M., Stahnke, T., and Richter-Landsberg, C. (2009). The small heat shock protein HSP25 protects astrocytes against stress induced by proteasomal inhibition. Glia 57, 1566-1577. doi: 10.1002/glia.20870
19. Goldbaum, O., Vollmer, G., and Richter-Landsberg, C. (2006). Proteasome inhibition by MG-132 induces apoptotic cell death and mitochondrial dysfunction in cultured rat brain oligodendrocytes but not in astrocytes. Glia 53, 891-901. doi: 10.1002/glia.20348
20. Grimm, S., Hohn, A., and Grune, T. (2012). Oxidative protein damage and the proteasome. Amino Acids 42, 23-38. doi: 10.1007/s00726-010-0646-8
21. Grune, T., Catalgol, B., Licht, A., Ermak, G., Pickering, A. M., Ngo, J. K., et al. (2011). HSP70 mediates dissociation and reassociation of the 26S proteasome during adaptation to oxidative stress. Free Radic. Biol. Med. 51, 1355-1364. doi: 10.1016/j.freeradbiomed.2011.06.015
22. Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., et al. (2009). Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392-395. doi: 10.1038/nature08221
23. Hasty, P., Livi, C. B., Dodds, S. G., Jones, D., Strong, R., Javors, M., et al. (2014). eRapa restores a normal life span in a FAP mouse model. Cancer Prev. Res. 7, 169-178. doi: 10.1158/1940-6207.CAPR-13-0299
24. Haynes, M. P., Sinha, D., Russell, K. S., Collinge, M., Fulton, D., Morales-Ruiz, M., et al. (2000). Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ. Res. 87, 677-682. doi: 10.1161/01.RES.87.8.677
25. Kruegel, U., Robison, B., Dange, T., Kahlert, G., Delaney, J. R., Kotireddy, S., et al. (2011). Elevated proteasome capacity extends replicative lifespan in Saccharomyces cerevisiae. PLoS Genet. 7:e1002253. doi: 10.1371/journal.pgen.1002253
26. Lamming, D. W., Demirkan, G., Boylan, J. M., Mihaylova, M. M., Peng, T., Ferreira, J., et al. (2014). Hepatic signaling by the mechanistic target of rapamycin complex 2 (mTORC2). FASEB J. 28, 300-315. doi: 10.1096/fj.13-237743
27. Lamming, D. W., Ye, L., Astle, C. M., Baur, J. A., Sabatini, D. M., and Harrison, D. E. (2013). Young and old genetically heterogeneous HET3 mice on a rapamycin diet are glucose intolerant but insulin sensitive. Aging Cell12, 712-718. doi: 10.1111/acel.12097
28. Liu, C.-W., Li, X., Thompson, D., Wooding, K., Chang, T.-I., Tang, Z., et al. (2006). ATP Binding and ATP hydrolysis play distinct roles in the function of 26S Proteasome. Mol. Cell 24, 39-50. doi: 10.1016/j.molcel.2006.08.025
29. Livingstone, M., Atas, E., Meller, A., and Sonenberg, N. (2010). Mechanisms governing the control of mRNA translation. Phys. Biol. 7:021001. doi: 10.1088/1478-3975/7/2/021001
30. Massey, A. C., Kiffin, R., and Cuervo, A. M. (2006). Autophagic defects in aging - Looking for an emergency exit?Cell Cycle 5, 1292-1296. doi: 10.4161/cc.5.12.2865
31. Mathew, A., Mathur, S. K., and Morimoto, R. I. (1998). Heat shock response and protein degradation: regulation of HSF2 by the ubiquitin-proteasome pathway. Mol. Cell Biol. 18, 5091-5098.
32. Miller, R. A., Harrison, D. E., Astle, C. M., Baur, J. A., Boyd, A. R., De Cabo, R., et al. (2011). Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J. Gerontol. A Biol. Sci. Med. Sci. 66, 191-201. doi: 10.1093/gerona/glq178
33. Miller, R. A., Harrison, D. E., Astle, C. M., Fernandez, E., Flurkey, K., Han, M., et al. (2014). Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction. Aging Cell13, 468-477. doi: 10.1111/acel.12194
34. Orr, M. E., Salinas, A., Buffenstein, R., and Oddo, S. (2014). Mammalian target of rapamycin hyperactivity mediates the detrimental effects of a high sucrose diet on Alzheimer's disease pathology. Neurobiol. Aging 35, 1233-1242. doi: 10.1016/j.neurobiolaging.2013.12.006
35. Osmulski, P. A., and Gaczynska, M. (2013). Rapamycin allosterically inhibits the proteasome. Mol. Pharmacol. 84, 104-113. doi: 10.1124/mol.112.083873
36. Pierce, A., Podlutskaya, N., Halloran, J. J., Hussong, S. A., Lin, P. Y., Burbank, R., et al. (2013). Over-expression of heat shock factor 1 phenocopies the effect of chronic inhibition of TOR by rapamycin and is sufficient to ameliorate Alzheimer's-like deficits in mice modeling the disease. J. Neurochem. 124, 880-893. doi: 10.1111/jnc.12080
37. Pierce, A., Wei, R., Halade, D., Yoo, S. E., Ran, Q., and Richardson, A. (2010). A Novel mouse model of enhanced proteostasis: full-length human heat shock factor 1 transgenic mice. Biochem. Biophys. Res. Commun. 402, 59-65. doi: 10.1016/j.bbrc.2010.09.111
38. Ponticelli, C. (2014). The pros and the cons of mTOR inhibitors in kidney transplantation. Exp. Rev. Clin. Immunol. 10, 295-305. doi: 10.1586/1744666X.2014.872562
39. Radhakrishnan, S. K., Lee, C. S., Young, P., Beskow, A., Chan, J. Y., and Deshaies, R. J. (2010). Transcription factor Nrf1 mediates the proteasome recovery pathway after proteasome inhibition in mammalian cells. Mol. Cell 38, 17-28. doi: 10.1016/j.molcel.2010.02.029
40. Rodriguez, K. A., Edrey, Y. H., Osmulski, P., Gaczynska, M., and Buffenstein, R. (2012). Altered composition of liver proteasome assemblies contributes to enhanced proteasome activity in the exceptionally long-lived naked mole-rat. PLoS ONE 7:e35890. doi: 10.1371/journal.pone.0035890
41. Rodriguez, K. A., Gaczynska, M., and Osmulski, P. A. (2010). Molecular mechanisms of proteasome plasticity in aging. Mech. Ageing Dev. 131, 144-155. doi: 10.1016/j.mad.2010.01.002
42. Rodriguez, K. A., Osmulski, P., Pierce, A., Weintraub, S. T., Gaczynska, M., and Buffenstein, R. (2014). A cytosolic protein factor from the naked mole-rat activates proteasomes of other species and protects these from inhibition.Biochim. Biophys. Acta. 1842, 2060-2072. doi: 10.1016/j.bbadis.2014.07.005
43. Ross, C. A., and Poirier, M. A. (2004). Protein aggregation and neurodegenerative disease. Nat. Med. 10(Suppl.). S10-S17. doi: 10.1038/nm1066
44. Sisoula, C., and Gonos, E. S. (2011). CHIP E3 ligase regulates mammalian senescence by modulating the levels of oxidized proteins. Mech. Ageing Dev. 132, 269-272. doi: 10.1016/j.mad.2011.04.003
45. Smith, D. M., Fraga, H., Reis, C., Kafri, G., and Goldberg, A. L. (2011). ATP binds to proteasomal ATPases in pairs with distinct functional effects, implying an ordered reaction cycle. Cell 144, 526-538. doi: 10.1016/j.cell.2011.02.005
46. Spilman, P., Podlutskaya, N., Hart, M. J., Debnath, J., Gorostiza, O., Bredesen, D., et al. (2010). Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease.PLoS ONE 5:e9979. doi: 10.1371/journal.pone.0009979
47. Sun, S. Y., Rosenberg, L. M., Wang, X., Zhou, Z., Yue, P., Fu, H., et al. (2005). Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition. Cancer Res. 65, 7052-7058. doi: 10.1158/0008-5472.CAN-05-0917
48. Sun, X. J., Goldberg, J. L., Qiao, L. Y., and Mitchell, J. J. (1999). Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway. Diabetes 48, 1359-1364. doi: 10.2337/diabetes.48.7.1359
49. Tai, H. C., Besche, H., Goldberg, A. L., and Schuman, E. M. (2010). Characterization of the brain 26S Proteasome and its interacting proteins. Front. Mol. Neurosci. 3:12. doi: 10.3389/fnmol.2010.00012
50. Thoreen, C. C., Chantranupong, L., Keys, H. R., Wang, T., Gray, N. S., and Sabatini, D. M. (2012). A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 485, 109-113. doi: 10.1038/nature11083
51. Umemura, A., Park, E. J., Taniguchi, K., Lee, J. H., Shalapour, S., Valasek, M. A., et al. (2014). Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition. Cell Metab. 20, 133-144. doi: 10.1016/j.cmet.2014.05.001
52. Vernace, V. A., Arnaud, L., Schmidt-Glenewinkel, T., and Figueiredo-Pereira, M. E. (2007). Aging perturbs 26S proteasome assembly in Drosophila melanogaster. FASEB J. 21, 2672-2682. doi: 10.1096/fj.06-6751com
53. Wan, X., Harkavy, B., Shen, N., Grohar, P., and Helman, L. J. (2007). Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism. Oncogene 26, 1932-1940. doi: 10.1038/sj.onc.1209990
54. Wilkinson, J. E., Burmeister, L., Brooks, S. V., Chan, C. C., Friedline, S., Harrison, D. E., et al. (2012). Rapamycin slows aging in mice. Aging Cell 11, 675-682. doi: 10.1111/j.1474-9726.2012.00832.x
55. Wullschleger, S., Loewith, R., and Hall, M. N. (2006). TOR signaling in growth and metabolism. Cell 124, 471-484. doi: 10.1016/j.cell.2006.01.016
56. Yeung, K. Y., and Ruzzo, W. L. (2001). Principal component analysis for clustering gene expression data.Bioinformatics 17, 763-774. doi: 10.1093/bioinformatics/17.9.763
57. Yu, C., Friday, B. B., Lai, J. P., Yang, L., Sarkaria, J., Kay, N. E., et al. (2006). Cytotoxic synergy between the multikinase inhibitor sorafenib and the proteasome inhibitor bortezomib in vitro: induction of apoptosis through Akt and c-Jun NH2-terminal kinase pathways. Mol. Cancer Ther. 5, 2378-2387. doi: 10.1158/1535-7163.MCT-06-0235
58. Yu, Z., Wang, R., Fok, W. C., Coles, A., Salmon, A. B., and Perez, V. I. (2014). Rapamycin and dietary restriction induce metabolically distinctive changes in mouse liver. J. Gerontol. A Biol. Sci. Med. Sci. doi: 10.1093/gerona/glu053. [Epub ahead of print].
59. Zanotto-Filho, A., Braganhol, E., Battastini, A. M., and Moreira, J. C. (2012). Proteasome inhibitor MG132 induces selective apoptosis in glioblastoma cells through inhibition of PI3K/Akt and NFkappaB pathways, mitochondrial dysfunction, and activation of p38-JNK1/2 signaling. Invest. New Drugs 30, 2252-2262. doi: 10.1007/s10637-012-9804-z
60. Zhang, Y., Bokov, A., Gelfond, J., Soto, V., Ikeno, Y., Hubbard, G., et al. (2014a). Rapamycin extends life and health in C57BL/6 mice. J. Gerontol. A Biol. Sci. Med. Sci. 69, 119-130. doi: 10.1093/gerona/glt056
61. Zhang, Y., Nicholatos, J., Dreier, J. R., Ricoult, S. J., Widenmaier, S. B., Hotamisligil, G. S., et al. (2014b). Coordinated regulation of protein synthesis and degradation by mTORC1. Nature 513, 440-443. doi: 10.1038/nature13492